Browse Items (106 total)

• Overview of the Ebola vaccines in pre-clinical and clinical development/Aperçu des vaccins Ebola en phase clinique et préclinique de développement

  Tags Diagnosis, Ebola, Epidemiology, Français, French, Outbreaks, Outcomes, R-PM, R-Res&Pub, Staffing, Staffing Model, Therapeutics, Viral Hemorrhagic Fever
  Creator: Buchy P.
  Subject: Contenu Français
  Item Type: Publication
  Date Last Updated: 2016-10-01
  Description: L’épidémie d’Ebola qui a sévit en Afrique de l’Ouest entre 2013 et 2016 a considérablement accéléré la recherche et le développement de vaccins Ebola.

• Ebola virus disease: Clinical presentation, prognosis and treatment/Maladie à virus Ebola : présentation clinique, aspects pronostiques et principes thérapeutiques

  Tags Diagnosis, Ebola, Epidemiology, Français, French, Outbreaks, Outcomes, R-PM, R-Res&Pub, Staffing, Staffing Model, Therapeutics, Viral Hemorrhagic Fever
  Creator: M. Aletti, H. Savini, C. Ficko, J. Bordes, A. Cambon, M. Billhot, G. Velut, et al.
  Subject: Contenu Français
  Item Type: Publication
  Date Last Updated: 2017-03-01
  Description: La présentation de la maladie à virus Ebola est protéiforme. Le spectre clinique va de formes gravissimes avec défaillances polyviscérales et décès en quelques jours à des formes paucisymptomatiques voire peut-être même asymptomatiques.
• 

  "Current status of drug treatment against the disease caused by the Ebola virus/Situación actual del tratamiento farmacológico
  frente a la enfermedad causada por el virus Ébola"

  Tags Ebola, Español, Outbreaks, R-Res&Pub, Spanish, Therapeutics, Viral Hemorrhagic Fever
  Creator: Reina J.
  Subject: Elementos en Español
  Item Type: Publication
  Date Last Updated: 2016-02-01
  Description: The recent epidemic of disease caused by the Ebola virus has highlighted the need to develop specific drugs and have to deal with this entity.

• Ebola: Prise en charge clinique des cas d'Ebola

  Tags Clinical Care Guidelines, Critical Care, Ebola, Français, French, Infection Prevention and Control, Patient Care, Personal Protective Equipment (PPE), R-PPE, Therapeutics
  
  Subject: Contenu Français
  Item Type: Online Course
  Date Last Updated: 2018
  Description: Online course created by the WHO. This course is also available in English.

• How to Steward Medical Countermeasures and Public Trust in an Emergency

  Tags Communications, Ebola, Prophylaxis, Public Health, Public Relations, R-EM, R-Res&Pub, Special Pathogens, Therapeutics
  Creator: Johns Hopkins Center for Health Security
  Subject: Emergency Management
  Item Type: Publication
  Date Last Updated: 2016-11-07
  Description: Summary Chapter 1 - Introduction Chapter 2 - Ebola Chapter 3 - Fukushima Chapter 4 - H1N1 InfluenzaChapter 5 - Anthrax Letters Enhanced Accessibility

• Recommendations for Assessment of Blood Donor Eligibility, Donor Deferral and Blood Product Management in Response to Ebola Virus

  Tags Ebola, Example, Lab, Laboratory, Public Health, R-T&C, Specimen Collection, Specimen Handling, Therapeutics
  Creator: U.S. Food and Drug Administration
  Subject: Treatment & Care
  Item Type: Guide
  Date Last Updated: 2017-01-01
  Description: This guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it…

  Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.

• Integrating Clinical Research into Epidemic Response

  Tags Clinical Trial, Ebola, Ethics, Master Protocol, Prophylaxis, R-Res&Pub, Research Design, Special Pathogens, Therapeutics
  Creator: National Academies Press
  Subject: Research
  Item Type: Publication
  Date Last Updated: 2017-04-12
  Description: Table of Contents   Front Matter i-xxvi Summary 1-18 1 Introduction 19-36 2 Conducting Clinical Research During an Epidemic 37-82 3 Assessment of Therapeutic Trials 83-112 4 Assessment of Vaccine Trials 113-154 5…

• Flexible Clinical Trial Design Suitable for Emerging Disease Outbreaks

  Tags Clinical Trial, Ebola, Master Protocol, Prophylaxis, R-Res&Pub, Research Design, Special Pathogens, Therapeutics
  Creator: U.S. Food and Drug Administration (FDA)
  Subject: Research
  Item Type: Guide
  Date Last Updated: 2018-08-13
  Description: FDA CDER statisticians are designing trials with adaptive features to make clinical evaluation of new drug treatments more efficient and informative. (FDA)More information on the subject can be read here.

• Consultation on Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) for Ebola Virus Disease (EVD)

  Tags Ebola, Prophylaxis, R-T&C, Therapeutics
  Creator: WHO
  Subject: Treatment & Care
  Item Type: Guide
  Date Last Updated: 2018-08-27
  Description: A group of independent scientific experts were convened by the WHO for the purpose of updating the May 2018 statement on MEURI for Ebola virus disease (EVD) during the current outbreak, 27 August 2018. (1)

• Threading the NEIDL (National Emerging Infectious Diseases Laboratories)

  Tags Basic Science Research, Biosafety, Ebola, Lab, Laboratory, R-Res&Pub, Therapeutics, Vaccine Study, Viral Hemorrhagic Fever
  Creator: American Society for Microbiology
  Subject: Research
  Item Type: Video
  Date Last Updated: 2018-01-02
  Description: This video explores the National Emerging Infectious Diseases Laboratories (NEIDL) security, a Biological Safety Level (BSL)-4 safety suit, and the facility.